ArticleAlzheimer's & dementia (New York, N. Y.)

Sex differences in treatment effects of lecanemab and donanemab: A Bayesian reanalysis of CLARITY-AD and TRAILBLAZER-ALZ2.

Stefan J Teipel et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.